STOK logo

Stoke Therapeutics, Inc. (STOK) Net income

annual net income:

-$88.98M+$15.72M(+15.01%)
December 31, 2024

Summary

  • As of today (August 20, 2025), STOK annual net profit is -$88.98 million, with the most recent change of +$15.72 million (+15.01%) on December 31, 2024.
  • During the last 3 years, STOK annual net income has fallen by -$3.18 million (-3.70%).
  • STOK annual net income is now -1500.95% below its all-time high of -$5.56 million, reached on December 31, 2017.

Performance

STOK Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSTOKincome statement metrics

quarterly net income:

-$23.48M-$136.36M(-120.80%)
June 30, 2025

Summary

  • As of today (August 20, 2025), STOK quarterly net profit is -$23.48 million, with the most recent change of -$136.36 million (-120.80%) on June 30, 2025.
  • Over the past year, STOK quarterly net income has increased by +$2.21 million (+8.61%).
  • STOK quarterly net income is now -120.80% below its all-time high of $112.88 million, reached on March 31, 2025.

Performance

STOK quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSTOKincome statement metrics

TTM net income:

$52.48M+$2.21M(+4.40%)
June 30, 2025

Summary

  • As of today (August 20, 2025), STOK TTM net profit is $52.48 million, with the most recent change of +$2.21 million (+4.40%) on June 30, 2025.
  • Over the past year, STOK TTM net income has increased by +$156.05 million (+150.67%).
  • STOK TTM net income is now at all-time high.

Performance

STOK TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSTOKincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

STOK Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+15.0%+8.6%+150.7%
3 y3 years-3.7%+4.7%+154.5%
5 y5 years-175.3%-81.2%+222.7%

STOK Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-3.7%+15.0%-120.8%+23.4%at high+148.4%
5 y5-year-175.3%+15.0%-120.8%+23.4%at high+148.4%
alltimeall time-1501.0%+15.0%-120.8%+23.4%at high+148.4%

STOK Net income History

DateAnnualQuarterlyTTM
Jun 2025
-
-$23.48M(-120.8%)
$52.48M(+4.4%)
Mar 2025
-
$112.88M(-1176.8%)
$50.27M(-156.5%)
Dec 2024
-$88.98M(-15.0%)
-$10.48M(-60.3%)
-$88.98M(-15.6%)
Sep 2024
-
-$26.43M(+2.9%)
-$105.46M(+1.8%)
Jun 2024
-
-$25.70M(-2.6%)
-$103.57M(-4.6%)
Mar 2024
-
-$26.37M(-2.2%)
-$108.53M(+3.7%)
Dec 2023
-$104.70M(+3.6%)
-$26.96M(+9.8%)
-$104.70M(+1.3%)
Sep 2023
-
-$24.54M(-19.9%)
-$103.40M(-1.5%)
Jun 2023
-
-$30.65M(+36.0%)
-$104.97M(+6.1%)
Mar 2023
-
-$22.55M(-12.1%)
-$98.96M(-2.1%)
Dec 2022
-$101.07M(+17.8%)
-$25.66M(-1.7%)
-$101.07M(+1.2%)
Sep 2022
-
-$26.11M(+5.9%)
-$99.86M(+3.6%)
Jun 2022
-
-$24.65M(+0.0%)
-$96.35M(+2.9%)
Mar 2022
-
-$24.65M(+0.8%)
-$93.66M(+9.2%)
DateAnnualQuarterlyTTM
Dec 2021
-$85.81M(+64.2%)
-$24.45M(+8.2%)
-$85.81M(+13.0%)
Sep 2021
-
-$22.60M(+2.9%)
-$75.92M(+13.3%)
Jun 2021
-
-$21.97M(+30.8%)
-$67.00M(+15.5%)
Mar 2021
-
-$16.79M(+15.3%)
-$58.00M(+11.0%)
Dec 2020
-$52.24M(+61.6%)
-$14.56M(+6.4%)
-$52.24M(+9.2%)
Sep 2020
-
-$13.68M(+5.6%)
-$47.84M(+11.9%)
Jun 2020
-
-$12.96M(+17.4%)
-$42.76M(+13.7%)
Mar 2020
-
-$11.04M(+8.7%)
-$37.62M(+16.4%)
Dec 2019
-$32.33M(+158.2%)
-$10.16M(+18.1%)
-$32.33M(+45.8%)
Sep 2019
-
-$8.60M(+10.0%)
-$22.16M(+63.4%)
Jun 2019
-
-$7.82M(+36.2%)
-$13.56M(+136.2%)
Mar 2019
-
-$5.74M(+200.3%)
-$5.74M(+200.3%)
Dec 2018
-$12.52M(+125.3%)
-
-
Mar 2018
-
-$1.91M
-$1.91M
Dec 2017
-$5.56M
-
-

FAQ

  • What is Stoke Therapeutics, Inc. annual net profit?
  • What is the all time high annual net income for Stoke Therapeutics, Inc.?
  • What is Stoke Therapeutics, Inc. annual net income year-on-year change?
  • What is Stoke Therapeutics, Inc. quarterly net profit?
  • What is the all time high quarterly net income for Stoke Therapeutics, Inc.?
  • What is Stoke Therapeutics, Inc. quarterly net income year-on-year change?
  • What is Stoke Therapeutics, Inc. TTM net profit?
  • What is the all time high TTM net income for Stoke Therapeutics, Inc.?
  • What is Stoke Therapeutics, Inc. TTM net income year-on-year change?

What is Stoke Therapeutics, Inc. annual net profit?

The current annual net income of STOK is -$88.98M

What is the all time high annual net income for Stoke Therapeutics, Inc.?

Stoke Therapeutics, Inc. all-time high annual net profit is -$5.56M

What is Stoke Therapeutics, Inc. annual net income year-on-year change?

Over the past year, STOK annual net profit has changed by +$15.72M (+15.01%)

What is Stoke Therapeutics, Inc. quarterly net profit?

The current quarterly net income of STOK is -$23.48M

What is the all time high quarterly net income for Stoke Therapeutics, Inc.?

Stoke Therapeutics, Inc. all-time high quarterly net profit is $112.88M

What is Stoke Therapeutics, Inc. quarterly net income year-on-year change?

Over the past year, STOK quarterly net profit has changed by +$2.21M (+8.61%)

What is Stoke Therapeutics, Inc. TTM net profit?

The current TTM net income of STOK is $52.48M

What is the all time high TTM net income for Stoke Therapeutics, Inc.?

Stoke Therapeutics, Inc. all-time high TTM net profit is $52.48M

What is Stoke Therapeutics, Inc. TTM net income year-on-year change?

Over the past year, STOK TTM net profit has changed by +$156.05M (+150.67%)
On this page